Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP881061.RAuy5WNAIHvkX4UEgJgH5WSnqJ2x4epCUzBqmliMJkM_M130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP881061.RAuy5WNAIHvkX4UEgJgH5WSnqJ2x4epCUzBqmliMJkM_M130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP881061.RAuy5WNAIHvkX4UEgJgH5WSnqJ2x4epCUzBqmliMJkM_M130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP881061.RAuy5WNAIHvkX4UEgJgH5WSnqJ2x4epCUzBqmliMJkM_M130_provenance.
- NP881061.RAuy5WNAIHvkX4UEgJgH5WSnqJ2x4epCUzBqmliMJkM_M130_assertion description "[The results of this study demonstrate that motesanib inhibited thyroid tumor xenograft growth predominantly through inhibition of angiogenesis and possibly via a direct inhibition of VEGFR2 and Ret expressed on tumor cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881061.RAuy5WNAIHvkX4UEgJgH5WSnqJ2x4epCUzBqmliMJkM_M130_provenance.
- NP881061.RAuy5WNAIHvkX4UEgJgH5WSnqJ2x4epCUzBqmliMJkM_M130_assertion evidence source_evidence_literature NP881061.RAuy5WNAIHvkX4UEgJgH5WSnqJ2x4epCUzBqmliMJkM_M130_provenance.
- NP881061.RAuy5WNAIHvkX4UEgJgH5WSnqJ2x4epCUzBqmliMJkM_M130_assertion SIO_000772 21422803 NP881061.RAuy5WNAIHvkX4UEgJgH5WSnqJ2x4epCUzBqmliMJkM_M130_provenance.
- NP881061.RAuy5WNAIHvkX4UEgJgH5WSnqJ2x4epCUzBqmliMJkM_M130_assertion wasDerivedFrom befree-2016 NP881061.RAuy5WNAIHvkX4UEgJgH5WSnqJ2x4epCUzBqmliMJkM_M130_provenance.
- NP881061.RAuy5WNAIHvkX4UEgJgH5WSnqJ2x4epCUzBqmliMJkM_M130_assertion wasGeneratedBy ECO_0000203 NP881061.RAuy5WNAIHvkX4UEgJgH5WSnqJ2x4epCUzBqmliMJkM_M130_provenance.
- befree-2016 importedOn "2016-02-19" NP881061.RAuy5WNAIHvkX4UEgJgH5WSnqJ2x4epCUzBqmliMJkM_M130_provenance.